Elizabeth Butler
Rheumatology · Atlanta, GANPI 1356316566
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 798 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Amgen at 25.7% of the total. Reporting peaked in 2022 at $4,391 and has fallen 98.6% since, to $61 in 2025.
Across 798 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$4K
- AbbVie$3K
- Lilly USA, LLC$964
- Johnson & Johnson$861
- Mallinckrodt Hospital Products Inc.$816
- GSK$770
- plus $6K from 26 others
What the payments were for
- Food & beverage$16,877100%
- Education$170%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 244 | $4,339 |
| AbbVie | 157 | $3,439 |
| Lilly USA, LLC | 49 | $964 |
| Johnson & Johnson | 40 | $861 |
| Mallinckrodt Hospital Products Inc. | 22 | $816 |
| GSK | 35 | $770 |
| UCB, Inc. | 35 | $624 |
| Novartis | 39 | $568 |
| E.r. Squibb & Sons, L.L.C. | 24 | $563 |
| Pfizer | 32 | $509 |
| Abiomed | 4 | $459 |
| AstraZeneca | 11 | $413 |
| Genentech USA, Inc. | 19 | $395 |
| Janssen Scientific Affairs, LLC | 3 | $376 |
| Sanofi-aventis U.S. LLC | 16 | $349 |
| Sobi, Inc | 12 | $224 |
| Bristol Myers Squibb | 17 | $211 |
| Medexus Pharma, Inc. | 9 | $190 |
| Abbott | 1 | $136 |
| ANI Pharmaceuticals, Inc. | 5 | $128 |
| Sanofi | 3 | $115 |
| Aurinia Pharma U.S., Inc. | 1 | $88 |
| Novo Nordisk | 4 | $78 |
| Radius Health, Inc. | 5 | $77 |
| Mallinckrodt Enterprises LLC | 3 | $54 |
| Exact Sciences | 2 | $33 |
| Hikma Pharmaceuticals USA | 1 | $26 |
| Medtronic | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Boehringer Ingelheim | 1 | $17 |
| Hologic Sales And Service, LLC | 1 | $16 |
| Fresenius Kabi USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$16,894 in reported general payments places this provider in the 75th percentile of 177 rheumatology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxychloroquine Sulfate | 26 | $823 |
| Celecoxib | 13 | $323 |
| Prednisone | 16 | $125 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Atlanta
- Gary MyersonAtlanta$1M
- William WilsonAtlanta$344K
- Paul SutejAtlanta$140K
- Sung LimAtlanta$125K
- Arezou KhosroshahiAtlanta$66K
- Kimberley WilsonAtlanta$41K
- John GoldmanAtlanta$33K
- Wambui MachuaAtlanta$31K
- Paula TanasaAtlanta$31K
- Rattandeep SinghAtlanta$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.